Omalizumab in Severe and Refractory Solar Urticaria

PHASE2CompletedINTERVENTIONAL
Enrollment

10

Participants

Timeline

Start Date

September 30, 2014

Primary Completion Date

September 29, 2015

Study Completion Date

September 29, 2015

Conditions
Solar Urticaria
Interventions
DRUG

Omalizumab

Trial Locations (13)

Unknown

CHU de Angers, Angers

Dermatology department, Centre Hospitalier Régional Universitaire, Besançon

CHU de Caen, Caen

CHU de Dijon, Dijon

CHU de Grenoble, Grenoble

CHRU de Lille, Lille

CHU de Limoges, Limoges

CHU de Montpellier, Montpellier

CHU de Nancy, Nancy

Dermatology department, Hôpital Saint-Louis, Paris

CHU de Reims, Reims

CHU de Rennes, Rennes

CHU de Toulouse, Toulouse

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Novartis

INDUSTRY

lead

Centre Hospitalier Universitaire de Besancon

OTHER